Terminal residues modulate DNA-binding site size and stability of the SSB-like DNA-binding protein Gp13 from bacteriophage Phi11 Authors: Vivek Ratre, Malabika Biswas Published: 2026 ABSTRACT Gp13 is a homodimeric single-stranded DNA-binding protein (SSB) from bacteriophage Phi11, harboring a C-terminal oligonucleotide/oligosaccharide-binding (OB) fold. To study the functional contributions of its terminal regions, a series of N- and C-terminal deletion mutants were generated and characterized using biochemical and biophysical approaches. Deletions in the N-terminal (residues 2–8) and C-terminal (residues 177–184) residues impaired ssDNA binding and reduced the minimal ssDNA binding size from 25 to 20 nucleotides, revealing that both the terminal regions contribute to efficient DNA interaction. Further deletions in the N-terminus abolished DNA binding, highlighting the potential role of residues R6-E12 in ssDNA binding. Size-exclusion chromatography showed that most mutants retained their dimeric state, suggesting that the dimerization domain lies outside Gp13’s terminal residues. Circular dichroism and intrinsic fluorescence analyses revealed localized secondary and tertiary changes in the mutants correlating with binding strength. In addition, Gp13 was found to associate with Staphylococcus aureus RecA in pull-down assays, suggesting a potential interaction between Phi11 SSB and host DNA recombination machinery. Together, these results elucidate the role of terminal residues of Gp13 in influencing the structure and ssDNA- binding properties of the protein.Supplementary InformationThe online version contains supplementary material available at 10.1038/s41598-026-49879-0. Introduction The most fundamental process in a living organism is the maintenance of its genetic material. The diverse processes involved in genome maintenance require managing various intermediate structures, which may be deleterious to the organism if not resolved. Unwinding of the double-stranded DNA (dsDNA) duplex results in ssDNA intermediates. These intermediates are thermodynamically less stable and often, spontaneously, lead to the formation of secondary structures, eventually hindering genome maintenance. ssDNA is more susceptible to attacks by chemicals and endogenous nucleases, which might lead to the degradation of the genetic material. To overcome the issue, cells produce SSB protein that binds to and stabilizes ssDNA and facilitates critical genomic processes. The SSB proteins are indispensable elements in all living organisms and have multiple domains to perform multiple functions1,2. The archetypal SSB from Escherichia coli (E. coli) consists of an N-terminal OB-fold (1–113 aa) and a C-terminal domain that can be distinguished into an intrinsically disordered linker (IDL, 113–169 aa) followed by an acidic tip/tail (169–177 aa)3,4. SSBs from various organisms can exhibit differences in architecture and the arrangement of domains. However, they all contain at least one OB-fold5. The location and the number of OB-fold may vary significantly in SSB proteins. Replication protein A (RPA) in eukaryotes consists of six OB-fold1,6,7. SSB encoded by most bacteria is a homotetramer, where each monomer contributes to one OB-fold. For example, E. coli SSB (EcoSSB) and Mycobacterium tuberculosis SSB (MtSSB) are homotetramers with an N-terminal OB-fold in each monomer8–10. Intriguingly, Deinococcus radiodurans SSB (DrSSB) forms a homodimer with two OB-folds in each monomer9,11–13. Cells infected by many bacteriophages and viruses express their own SSBs. Most of them bear only one OB-fold per monomer. The oligomeric status, which represents the active forms of these proteins, can vary significantly. Some proteins are found as monomers, such as the T4 gene product 32 (gp32)14. Others exist as dimers, like Phi11 Gp1315 and T7 gene product 2.5 (gp2.5)16,17. Additionally, some proteins are hexamers, such as the SSB of phage GA-118. Interestingly, SSB, LEF-3 from Helicoverpa armigera nucleopolyhedrovirus (HaLEF-3) is distinct among all other SSBs reported. HaLEF-3 forms an octamer in its ssDNA-free (apo) state, and each monomer contains three OB-folds: N-terminal OB1 (part of Domain I(DI)); OB2 and OB3 make up Domain II (DII)19. While the N-terminal domain plays a role in ligand binding and oligomerization3,4,20, the IDL of SSB is one of the few regions universally conserved for its tendency toward structural disorder, though its length and amino acid composition vary21–23. Contrary to that, the acidic C-terminal peptide (CTP) or acidic tail is highly conserved and its primary function is to facilitate interaction of the EcoSSB with at least 18 SSB-interacting proteins (SIPs), essential for nucleic acid metabolism24–26. Mutations in CTP lead to weakening of protein-protein interactions and are lethal to cells26,27. Alternatively, the CTP is believed to have a regulatory function rather than mediating a direct protein-protein interaction28. The IDL of EcoSSB has three conserved PXXP motifs that mediate binding to OB-folds present in SSB and its interacting partners. Point mutations in either the PXXP motif or the OB-fold of the interacting partner have completely abolished the SSB binding26. The PXXP motif is indeed widespread across many organisms. However, it is not universally present in SSB across all classes of life29. Thus, it is imperative that in some organisms, the C-terminal acidic tip is indeed a hub for protein-protein interaction. In the present study, a series of N- and C-terminal deletion mutants of Phi11 Gp13 were constructed, purified, and characterized by biochemical and biophysical approaches. In our previous study, we showed that the OB-fold of Gp13 is present in the C-terminal region, followed by an acidic tail15. However, the exact function of the N-terminal domain remained unresolved. To address this, we purified various N and C-terminal deletion mutants of Gp13 and tried to determine the region involved in oligomerization, the boundaries of the binding site, and the important residues that regulate the DNA binding activity. Additionally, a mutant with a deletion in the acidic tail was generated to determine whether this region contributes to Gp13’s interaction with other proteins involved in the nucleic acid machinery, and whether its deletion would lead to a loss of activity. Results Overexpression and purification of Gp13 and its deletion mutants Gp13 and its N- and C-terminal deletion mutants were individually expressed in a soluble form and were purified to high purity from 1 L cultures of E. coli BL21(λDE3) cells. A schematic representation of each mutant and its deleted residues is shown in Fig. 1a. Immobilized Metal Affinity Chromatography (IMAC) (Ni²⁺-NTA) was employed for the purification of the histidine-tagged proteins. The purified proteins were analyzed by 15% SDS-PAGE (Fig. 1b, c). All purified proteins migrated as a single band at ⁓20 kDa, consistent with the calculated molecular weight of the monomer as predicted by the EMBOSS Pepstats online tool30. The mutant N3 could not be purified as an intact protein due to substantial degradation during purification and was therefore not used for any further analysis, Table 1.Fig. 1Gp13 and its deletion mutants used in the current study. (a) The Gp13 and its mutant proteins are shown in schematic form, divided into N-terminal (blue), C-terminal OB-fold (black), and acidic tail (red). (b) Overexpression and purification of his-tagged Gp13 mutants. Proteins were separated on 15% SDS-PAGE and stained with Coomassie brilliant blue R-250. Lanes show the purified N-terminal deletion mutants N1, N2, N4, and N5, followed by the 200 kDa molecular weight marker (M), wild-type Gp13, and the C-terminal deletion mutants C1 and C2. (c) Overexpression and purification of his-tagged N3 mutant. Lane M, 200 kDa molecular weight marker and lane 1, N3.For presentation purposes, gel images shown in the main figures were cropped to remove the stacking gel region where applicable. No other modifications were made. Uncropped gel images, including gel edges and replicate experiments, are provided in the Supplementary Information [Fig. S2]. In some cases, the stacking gel region is not visible as it was not retained in the original image files. Gp13 and its deletion mutants used in the current study. (a) The Gp13 and its mutant proteins are shown in schematic form, divided into N-terminal (blue), C-terminal OB-fold (black), and acidic tail (red). (b) Overexpression and purification of his-tagged Gp13 mutants. Proteins were separated on 15% SDS-PAGE and stained with Coomassie brilliant blue R-250. Lanes show the purified N-terminal deletion mutants N1, N2, N4, and N5, followed by the 200 kDa molecular weight marker (M), wild-type Gp13, and the C-terminal deletion mutants C1 and C2. (c) Overexpression and purification of his-tagged N3 mutant. Lane M, 200 kDa molecular weight marker and lane 1, N3.For presentation purposes, gel images shown in the main figures were cropped to remove the stacking gel region where applicable. No other modifications were made. Uncropped gel images, including gel edges and replicate experiments, are provided in the Supplementary Information [Fig. S2]. In some cases, the stacking gel region is not visible as it was not retained in the original image files. Changes in the binding site size Binding of each mutant to oligonucleotides of various lengths [(dT)20, (dT)25, (dT)30, and (dT)50], was investigated using increasing concentrations of the mutant proteins. Mutants C1 and C2 bound to oligonucleotides of all tested lengths, including (dT)20 (Fig. 2a-d), unlike wild-type Gp13 which did not exhibit any detectable binding to (dT)20 under similar conditions, as reported in our previous work31. The N-terminal deletion mutant N1 also bound all tested oligonucleotides—(dT)20, (dT)25, (dT)30, and (dT)50 (Fig. 2e, f). However, N1 did not reach complete binding saturation with (dT)20 or (dT)25, even at concentrations of 1–3 µM (as assessed from the absence of further mobility shift upon increasing protein concentration). In comparison, wild-type Gp13 achieves complete binding to (dT)25 at 2.5–3 µM31. Mutants N2 and N4 failed to bind (dT)20 and (dT)25 but showed weak binding to (dT)30 and (dT)50 at higher protein concentrations (Fig. 2g-j). Binding was abolished entirely in the case of N5 (Fig. 2k, l) with all tested oligonucleotides. Table 2 summarizes the DNA binding affinity of wild-type and the deletion mutants of Gp13 to oligo (dT) of varying lengths (20, 25, 30, and 50 nucleotides).Fig. 2Comparison of ssDNA binding activity of Gp13 mutants. The ssDNA binding activity of the deletion mutants of Gp13 was analyzed using oligo(dT)ₙ (n = 20, 25, 30, 50). A fixed concentration of 300 nM oligo(dT)ₙ was incubated with 1, 2, and 3 µM of the purified mutants: C1 (a, b) and C2 (c, d), and N-terminal deletion mutants N1 (e, f), N2 (g, h), N4 (i, j), and N5 (k, l). The resulting protein–DNA complexes were separated, visualized and analysed as described previously15. Comparison of ssDNA binding activity of Gp13 mutants. The ssDNA binding activity of the deletion mutants of Gp13 was analyzed using oligo(dT)ₙ (n = 20, 25, 30, 50). A fixed concentration of 300 nM oligo(dT)ₙ was incubated with 1, 2, and 3 µM of the purified mutants: C1 (a, b) and C2 (c, d), and N-terminal deletion mutants N1 (e, f), N2 (g, h), N4 (i, j), and N5 (k, l). The resulting protein–DNA complexes were separated, visualized and analysed as described previously15. Table 1List of the primers for the construction of plasmids used in the current study. The recognition site for the restriction endonuclease in the primer is underlined.SerialNo.PlasmidPrimer1C1-BamHIAAAGGATCCATGAAAATCACTGGTAGAACACAATAC2C1-XhoIGGGCTCGAGCTAATTGATTTCTATTGGACCATTAGCATT3C2-BamHIAAAGGATCCATGAAAATCACTGGTAGAACACAATAC4C2-XhoIGAACTCGAGCTATTCTATTGGACCATTAGCATTAGCGAA5N1-BamHIAGGGGATCCATGACTGGTAGAACACAATACATTCAA6N1-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT7N2-BamHIAGGGGATCCATGAGAACACAATACATTCAAGAAACT8N2-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT9N3-BamHIAGGGGATCCATGCAATACATTCAAGAAACTAATCAA10N3-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT11N4-BamHIAGGGGATCCATGATTCAAGAAACTAATCAAGAGGCATTC12N4-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT13N5-BamHIAGGGGATCCATGACTAATCAAGAGGCATTCATGAAAGGTGGG14N5-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT Table 1List of the primers for the construction of plasmids used in the current study. The recognition site for the restriction endonuclease in the primer is underlined.SerialNo.PlasmidPrimer1C1-BamHIAAAGGATCCATGAAAATCACTGGTAGAACACAATAC2C1-XhoIGGGCTCGAGCTAATTGATTTCTATTGGACCATTAGCATT3C2-BamHIAAAGGATCCATGAAAATCACTGGTAGAACACAATAC4C2-XhoIGAACTCGAGCTATTCTATTGGACCATTAGCATTAGCGAA5N1-BamHIAGGGGATCCATGACTGGTAGAACACAATACATTCAA6N1-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT7N2-BamHIAGGGGATCCATGAGAACACAATACATTCAAGAAACT8N2-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT9N3-BamHIAGGGGATCCATGCAATACATTCAAGAAACTAATCAA10N3-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT11N4-BamHIAGGGGATCCATGATTCAAGAAACTAATCAAGAGGCATTC12N4-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT13N5-BamHIAGGGGATCCATGACTAATCAAGAGGCATTCATGAAAGGTGGG14N5-XhoIAAACTCGAGCTAGAACGGTAAATCATCATCATT List of the primers for the construction of plasmids used in the current study. The recognition site for the restriction endonuclease in the primer is underlined. Effect of mutations on the oligomeric status The oligomeric status of the N- and C-terminal deletion mutants of Gp13 was analyzed by employing size-exclusion chromatography (SEC). The elution volume for each protein was compared against a standard calibration curve (Fig. 3) generated using molecular weight markers. The apparent molecular weights (MW) of the proteins were calculated and are summarized in Table 3. The calculated molecular weight of the truncated mutants suggests that all mutants adopt a dimeric configuration, like the wild-type Gp1315. These results indicate that the dimerization domain of Gp13 is unaffected by the N-terminal or C-terminal deletions under native conditions, suggesting that the dimer interface resides in the conserved central domain. An overlay of the SEC chromatograms for all deletion mutants and molecular-weight standards is provided as Supplementary Figure S1, confirming the homogeneity of the protein samples. We further conclude that each deletion mutant predominantly adopts a dimeric configuration in solution.Fig. 3Size exclusion analysis of Gp13 mutants. The standard linear regression curve was generated by plotting the elution volume against the log molecular weight of the standard proteins. The standard proteins are represented as follows: the square represents insulin (5.1 kDa), the triangle represents Heat Shock Protein (HSP, 10 kDa), the circle represents Human Growth Hormone (HGH, 22.1 kDa), and the pentagon represents bovine serum albumin (BSA, 66 kDa). Size exclusion analysis of Gp13 mutants. The standard linear regression curve was generated by plotting the elution volume against the log molecular weight of the standard proteins. The standard proteins are represented as follows: the square represents insulin (5.1 kDa), the triangle represents Heat Shock Protein (HSP, 10 kDa), the circle represents Human Growth Hormone (HGH, 22.1 kDa), and the pentagon represents bovine serum albumin (BSA, 66 kDa). Table 2Impact of N- and C-terminal deletions in Gp13 on its DNA binding activity and binding site size.ProteinBinding to (dT)20Binding to (dT)25Binding to (dT)30Binding to (dT)50Max % Binding AchievedShift in Minimal BindingLengthObservationsPosition of amino acid deletedC1(C-terminal deletion)YesYesYesYes100%↓ 20 ntBinding to shorter oligonucleotides, possibly due to altered structural constraints.D179-D180-D181- L182-P183-F184C2(C-terminal deletion)YesYesYesYes100%↓ 20 ntSimilar behavior to C1I177-N178-D179-D180-D181-L182-P183-F184N1(N-terminal deletion)YesYesYesYes100%↓ 20 ntAlso shows relaxed substrate specificityK2-I3N2(N-terminal deletion)NoNoWeak (at high conc.)Weak (at high conc.)≤ 50%≤ 30 ntReducedbinding; length requirement increasedK2-I3-T4-G5N4(N-terminaldeletion)NoNoWeak (at highconc.)Weak (at highconc.)≤ 30%≤ 30 ntSimilar to N2, partial activity is retained at higher oligo lengthK2-I3-T4-G5-R6-T 7-Q8-Y9N5(N-terminal deletion)NoNoNoNo0%No bindingBinding abolished entirelyK2-I3-T4-G5-R6-T7-Q8-Y9-I10-Q11-E12 Table 2Impact of N- and C-terminal deletions in Gp13 on its DNA binding activity and binding site size.ProteinBinding to (dT)20Binding to (dT)25Binding to (dT)30Binding to (dT)50Max % Binding AchievedShift in Minimal BindingLengthObservationsPosition of amino acid deletedC1(C-terminal deletion)YesYesYesYes100%↓ 20 ntBinding to shorter oligonucleotides, possibly due to altered structural constraints.D179-D180-D181- L182-P183-F184C2(C-terminal deletion)YesYesYesYes100%↓ 20 ntSimilar behavior to C1I177-N178-D179-D180-D181-L182-P183-F184N1(N-terminal deletion)YesYesYesYes100%↓ 20 ntAlso shows relaxed substrate specificityK2-I3N2(N-terminal deletion)NoNoWeak (at high conc.)Weak (at high conc.)≤ 50%≤ 30 ntReducedbinding; length requirement increasedK2-I3-T4-G5N4(N-terminaldeletion)NoNoWeak (at highconc.)Weak (at highconc.)≤ 30%≤ 30 ntSimilar to N2, partial activity is retained at higher oligo lengthK2-I3-T4-G5-R6-T 7-Q8-Y9N5(N-terminal deletion)NoNoNoNo0%No bindingBinding abolished entirelyK2-I3-T4-G5-R6-T7-Q8-Y9-I10-Q11-E12 Impact of N- and C-terminal deletions in Gp13 on its DNA binding activity and binding site size. C1 (C-terminal deletion) C2 (C-terminal deletion) N1 (N-terminal deletion) N2 (N-terminal deletion) N4 (N-terminal deletion) Weak (at high conc.) Weak (at high conc.) N5 (N-terminal deletion) Effect of mutations on the secondary and tertiary structure of the proteins To investigate the secondary structural characteristics of the wild-type Gp13 protein and its N- and C-terminal deletion mutants, far-UV CD was employed. The various mutants and the wild-type protein exhibited clear negative ellipticity minima near 208 nm and 222 nm suggesting the presence of a mixture of α-helical and β-sheet content. However, considerable variations were observed in spectral intensity and curvature among the deletion mutants (Fig. 4a).Fig. 4Analysis of variations in the secondary and tertiary structure of the Gp13 mutants. (a) Far-UV CD spectrum for all the Gp13 mutants was obtained in Dialysis buffer (Tris-chloride, pH 7.5, NaCl 150 mM and 5% Glycerol) at a concentration of 10 µM. (b) Intrinsic tryptophan fluorescence for Gp13 mutants was measured by exciting the protein samples at 295 nm and recording the emission spectra between 300 and 460 nm. Analysis of variations in the secondary and tertiary structure of the Gp13 mutants. (a) Far-UV CD spectrum for all the Gp13 mutants was obtained in Dialysis buffer (Tris-chloride, pH 7.5, NaCl 150 mM and 5% Glycerol) at a concentration of 10 µM. (b) Intrinsic tryptophan fluorescence for Gp13 mutants was measured by exciting the protein samples at 295 nm and recording the emission spectra between 300 and 460 nm. The secondary structural content of the investigated proteins was quantified by deconvolution of the CD spectra using the BeStSel algorithm32,33. BeStSel analysis revealed that Gp13 exhibited 9.9% α-helix, 28.0% antiparallel β-sheet, and 45.0% random coil (Table 4). Among the C-terminal mutants, C1 retained the α-helical content (9.7%) similar to Gp13, whereas C2 showed increased α-helical (14.1%) and parallel β-sheet content (12.8%) indicating a structural rearrangement in secondary structure distribution. Table 3Apparent molecular weights of Gp13 deletion mutants were determined by size-exclusion chromatography using protein standards (Table 2).ProteinsSampleM.wtLog. M.WtRTElution Volume (mL)EV = RT x Flow rateCode(kDa)Sample-1N143.41.6411.106.66Sample-2N243.21.6411.116.67Sample-4N443.01.6311.126.67Sample-6N543.41.6411.106.66Sample-7C143.91.6411.086.65Sample-8C243.41.6411.106.66 Table 3Apparent molecular weights of Gp13 deletion mutants were determined by size-exclusion chromatography using protein standards (Table 2).ProteinsSampleM.wtLog. M.WtRTElution Volume (mL)EV = RT x Flow rateCode(kDa)Sample-1N143.41.6411.106.66Sample-2N243.21.6411.116.67Sample-4N443.01.6311.126.67Sample-6N543.41.6411.106.66Sample-7C143.91.6411.086.65Sample-8C243.41.6411.106.66 Apparent molecular weights of Gp13 deletion mutants were determined by size-exclusion chromatography using protein standards (Table 2). The N-terminal deletion mutants N1, N2, and N4 exhibited a characteristic ellipticity minimum at 208 and 222 nm in their CD spectrum, indicative of slightly elevated α-helical content (~ 15–16%) in comparison to the wild-type protein. The mutant N5 showed a spectrum with α-helical signatures higher than Gp13, indicative of changes in secondary structure These results are also consistent with the intrinsic tryptophan fluorescence data, where N1, C1, and C2 exhibited minimal changes in the λmax, ranging from ⁓335.5 nm (for N1) to ⁓338 nm (for C1 and C2), as shown in Fig. 4b. N2 and N4 exhibited red shifts in fluorescence emission (λmax at 338.5 nm and ~ 335.5 nm, respectively), suggesting perturbations in tertiary structure. N5 showed an increase in the fluorescence intensity and a substantial red shift (λmax 342.5), indicating perturbations in its tertiary structure (Fig. 4b). Together, the CD and fluorescence data suggest that most Gp13 deletion mutants retain an overall Gp13-like fold, although local structural changes—most pronounced in C2 and N5—correlate with the observed reductions in ssDNA-binding ability. Phi11 Gp13 interacts with host RecA To investigate whether Gp13 interacts with host RecA, we performed a pull-down assay and assessed the effect of deleting the C-terminal acidic tail. Gp13 or the truncated mutant C1 (both histidine- tagged) was first incubated with ssDNA and then with tag-less RecA. Control reactions confirmed that RecA alone did not bind the Ni–NTA matrix (Fig. 5a), demonstrating assay specificity. When RecA was incubated with Gp13- or C1-ssDNA complexes, it was recovered in the eluted fractions (Fig. 5b, c), indicating that both wild-type and C-terminal truncated Gp13 can physically associate with RecA. Although the assay does not distinguish between direct interaction and ssDNA-mediated association, deletion of the acidic tail did not abolish RecA binding. These results suggest that Phi11 Gp13 associates with host RecA under the assay conditions and that the C-terminal acidic tail is not essential for this interaction, although it may play a regulatory role.Fig. 5Ni-NTA Pull-Down Assay Demonstrating Interaction of His-Tagged Gp13 and His-Tagged C1 with Tagless RecA. The interaction between his-tagged Gp13 and C1 with tagless RecA was carried out using Ni-NTA beads, and further analysed on 12% SDS-PAGE. (a) Tagless RecA alone was added to the Ni-NTA column, lane 1: Flow through (FT), lane 2: Wash, lane 3: Elution. (b) His-tagged Gp13 and tagless RecA were allowed to interact and added to Ni NTA beads, lane 1: FT, lane 2: Wash, Lane 3: copurified Gp13 and RecA with 300 mM imidazole. (c) His-tagged C1 and tagless RecA were allowed to interact and added to Ni-NTA beads, lane 1: FT, lane 2: Wash, Lane 3: copurified C1and RecA with 300 mM imidazole.For presentation purposes, gel images shown in the main figures were cropped to remove the stacking gel region where applicable. No other modifications were made. Uncropped gel image, including gel edges is provided in the Supplementary Information [Fig. S3]. Ni-NTA Pull-Down Assay Demonstrating Interaction of His-Tagged Gp13 and His-Tagged C1 with Tagless RecA. The interaction between his-tagged Gp13 and C1 with tagless RecA was carried out using Ni-NTA beads, and further analysed on 12% SDS-PAGE. (a) Tagless RecA alone was added to the Ni-NTA column, lane 1: Flow through (FT), lane 2: Wash, lane 3: Elution. (b) His-tagged Gp13 and tagless RecA were allowed to interact and added to Ni NTA beads, lane 1: FT, lane 2: Wash, Lane 3: copurified Gp13 and RecA with 300 mM imidazole. (c) His-tagged C1 and tagless RecA were allowed to interact and added to Ni-NTA beads, lane 1: FT, lane 2: Wash, Lane 3: copurified C1and RecA with 300 mM imidazole.For presentation purposes, gel images shown in the main figures were cropped to remove the stacking gel region where applicable. No other modifications were made. Uncropped gel image, including gel edges is provided in the Supplementary Information [Fig. S3]. Discussion In this study, we mapped the functional domains in Phi11 Gp13 by creating a series of N-terminal and C-terminal truncated mutants. By employing DNA-binding assays, secondary and tertiary structural analyses, and protein–protein interaction studies, we examined how deletions influence the structure, stability, and activity of Gp13 (summarized in Table 5). Table 4The comparison of the percentage of various secondary structural components of Gp13 and its mutants.Sec Structure content%C1C2N1N2N4N5Gp13α-Helix9.714.11515.41615.09.9Antiparallel β-Sheet2523.224.818.922.120.828Parallel β-Sheet012.83.85.76.97.50.4Turn17.114.815.415.213.914.816.8Random Coils48.235.141.144.840.841.945RMSD0.01780.0480.05090.02770.03470.04230.0225 Table 4The comparison of the percentage of various secondary structural components of Gp13 and its mutants.Sec Structure content%C1C2N1N2N4N5Gp13α-Helix9.714.11515.41615.09.9Antiparallel β-Sheet2523.224.818.922.120.828Parallel β-Sheet012.83.85.76.97.50.4Turn17.114.815.415.213.914.816.8Random Coils48.235.141.144.840.841.945RMSD0.01780.0480.05090.02770.03470.04230.0225 The comparison of the percentage of various secondary structural components of Gp13 and its mutants. We report that specific terminal deletions can alter the DNA binding site size of Gp13. Previously, we have reported that wild-type Gp13 binds ssDNA with a minimum binding site size of 25 nucleotides31. This study reveals that mutants C1, C2, and N1 bound to shorter oligonucleotides ((dT)20), which Gp13 failed to bind to (Fig. 2a, c, e), indicating a shift in the binding site size from 25 to 20 nucleotides. To our knowledge, this is the first demonstration of such a reduction in minimal binding length in Phi11 Gp13. In contrast, N2 and N4 showed no binding to (dT)20 and (dT)25 and a weaker binding to longer oligonucleotides such as (dT)30 and (dT)50 (Fig. 2h, j). These results suggest that the first 10–12 amino acid residues (K2-I3-T4-G5-R6-T 7-Q8-Y9-I10-Q11-E12) in the N-terminal end of the protein contribute to maintaining a conformation compatible for binding longer oligonucleotides. Our previous studies showed that in wild-type Gp13, the OB-fold is followed by an acidic tail15, which may restrict access to the core binding domain. In the mutant C1, the removal of the acidic tail likely exposed the OB-fold and led to better accessibility of the core OB domain to the substrate, thereby facilitating binding to (dT)20. CD spectra revealed that N1 and N4 generally maintained stable conformations when compared to wild-type Gp13 (Fig. 4a). However, deconvolution of the spectra showed a significant increase in the α-helical content (Table 4). N5 exhibited increased negative ellipticity at 208 and 222 nm, indicative of structural destabilization. For C2, a reduced peak was observed at 208 nm and 222 nm, also suggesting structural destabilization, with a significant increase in both α-helical content (9.9 to 14.1%) and parallel β-sheets (from 0.4% in Gp13 to 12.8%). The intrinsic tryptophan fluorescence data also showed that deletions from both the N-terminal and C-terminal residues had little to no impact on the overall protein structure. However, C2 showed a shift in λmax, and N5 showed an increase in fluorescence intensity as well as a shift in λmax, suggesting structure destabilization (Fig. 4a and b; Table 4). The above results corroborated with the EMSA data, where N1, N2, N4, C1, and C2 showed binding with the tested oligo (dT) [though N2 and N4 failed to bind (dT)20], while N5 completely lost its binding ability. The C-terminal region of bacterial SSB proteins is a hub for protein-protein interactions, which is essential for coordinating various DNA metabolic processes. SSB proteins typically consist of an N-terminal globular domain, which comprises an OB-fold and an oligomerization domain. The C-terminal has a characteristic intrinsically disordered linker [IDL] region followed by an acidic tip with consensus sequence DDDI/LPF. The most significant role of the IDL and SSB C-terminal acidic tip is to act as a binding site for numerous SSB-interacting proteins (SIPs), which are essential for coordinating various aspects of DNA metabolism4,34–36. The C-terminal acidic tip is highly conserved and mutations or deletions in this region can be deleterious or even lethal, highlighting its importance in cellular viability24,37,38. To examine the role of the C-terminal acidic tail in Gp13, we investigated the interaction of wild-type Gp13 and a C-terminal deletion mutant (C1, lacking the acidic tip) with RecA. RecA is a key protein in bacterial DNA metabolism, playing critical roles in maintaining genomic integrity and adapting to stress. Its primary functions include SOS response, homologous recombination, prophage induction, etc39–43.. Crucially, in S. aureus, RecA plays a central role by initiating a cascade of events that help bacteriophage Phi11 regulate its lytic-lysogeny development switch40,44. The interaction between EcoSSB and RecA protein has been extensively studied. While some studies suggest that RecA binds to ssDNA even in the presence of SSB protein, its enzymatic activities are regulated by SSB-induced structural alterations of ssDNA rather than directly interacting with SSB45. A more recent study showed that nucleation of RecA on ssDNA does not happen passively; instead, it interacts directly with SSB. The study also showed that a deletion in the C-terminal region significantly hindered the RecA filament formation46. Given the well-established importance of SSB C-termini in recruiting SIPs and the extensive evidence for SSB–RecA interactions across bacterial systems46–48 we sought to examine whether Phi11 Gp13 engages in a similar interaction with S. aureus RecA. The observations from results obtained from the pull-down assay indicate that Phi11 Gp13 associates with S. aureus RecA (Fig. 5) and, in turn, may modulate RecA binding to the cognate DNA. The ability of C1 to retain RecA binding suggests that, in the context of Phi11 Gp13, the acidic tail may serve a regulatory function rather than being the sole determinant of RecA association. Despite the observed functional alterations, most of the deletion mutants in this study largely retained their dimeric oligomeric state, indicating the presence of the oligomerization interface away from the terminal regions of the protein. However, this makes it challenging to determine which terminal comprises the oligomerization domain. The current study demonstrates how the primary sequence of Gp13, its three-dimensional structure, and its functional activity are interlinked. Even minor changes like terminal deletions can lead to a detectable change in a protein structure and stability, which in turn affects its ability to interact with ligand molecules (DNA/protein), highlighting the delicate balance required for protein function. Materials and methods Materials The gp13 coding sequence from Staphylococcus aureus phage Φ11 was obtained from the NCBI Reference Sequence database (phage genome accession NC_004615; protein accession NP_803266.1, GeneID: 1258063). E. coli DH5α cells were used as a cloning host, and BL21 (DE3) was used for overexpression of Gp13 and the deletion mutants cloned in the expression vector pET28a (Novagen, Madison, WI, USA). DNA polymerase, BamHI, XhoI, and the DNA ligation kit (K1422) were procured from Thermo Scientific (USA). Luria–Bertani (LB) broth, Isopropyl β-D-1-thiogalactopyranoside (IPTG), Dithiothreitol (DTT), Phenylmethylsulphonyl fluoride (PMSF) and Kanamycin were procured from HiMedia. Ni-NTA resin (88221) was purchased from ThermoFisher. Bradford reagent for protein estimation was obtained from GeNei. SYBR Green II RNA Gel Stain was used for EMSA visualization (Invitrogen). TEV protease (P8112S) for histidine tag removal was procured from New England Biolabs. Primers and single-stranded oligonucleotides were procured from Barcode Biosciences. All reagents were of molecular biology grade and were prepared according to the manufacturer’s protocol. Construction of plasmids for Gp13 mutants To determine the possible involvement of the N- and C-terminal residues of Gp13 in the structure and function of the protein, we constructed a series of C-terminal (C1, C2) and N-terminal (N1, N2, N4, N5) deletion mutants of Gp13. Polymerase chain reaction was employed for mutant generation using pGp1315 as the template. To directionally clone the PCR products into the pET28a vector (Novagen Inc., Madison, WI, USA), BamHI and XhoI restriction sites were incorporated at the 5’ and 3’ ends of each amplified fragment. The primers (with restriction sites underlined) used for mutant construction are summarized in Table 1. Table 5Impact of mutations on the secondary structure and ssDNA binding activity of Gp13.ProteinDNA binding propertyMinimum Oligo LengthBoundHelix (%)Antiparallel Sheet (%)Parallel Sheet(%)Turn (%)Random Coil (%)RMSDInterpretationWT Gp13Retained [no binding observed with (dT)20]25 nt9.928.00.416.845.00.0225Native fold with balanced flexibility; binds 25 nt oligos efficiently30C1Retained20 nt9.725.00.017.148.20.0178Deletion likely relieves structural constraints; allows binding toshorter oligos.C2Retained20 nt14.123.212.814.835.10.0480similar bindingbehavior to C1N1Retained [binding efficiency slightly reduced]20 nt15.024.83.815.441.10.0509Improved accessibility for short oligos due toN-terminal deletionN2Weak≥ 30 nt15.418.95.715.244.80.0277Significant reduction in antiparallel content suggests reduced stability and affectsbinding30N4Weak≥ 30 nt16.022.17.513.940.80.0347Binding abolished;deletion likely affectsN5No bindingND15.034.76.914.246.70.0333Exhibits the largest structural perturbationaffecting the binding Table 5Impact of mutations on the secondary structure and ssDNA binding activity of Gp13.ProteinDNA binding propertyMinimum Oligo LengthBoundHelix (%)Antiparallel Sheet (%)Parallel Sheet(%)Turn (%)Random Coil (%)RMSDInterpretationWT Gp13Retained [no binding observed with (dT)20]25 nt9.928.00.416.845.00.0225Native fold with balanced flexibility; binds 25 nt oligos efficiently30C1Retained20 nt9.725.00.017.148.20.0178Deletion likely relieves structural constraints; allows binding toshorter oligos.C2Retained20 nt14.123.212.814.835.10.0480similar bindingbehavior to C1N1Retained [binding efficiency slightly reduced]20 nt15.024.83.815.441.10.0509Improved accessibility for short oligos due toN-terminal deletionN2Weak≥ 30 nt15.418.95.715.244.80.0277Significant reduction in antiparallel content suggests reduced stability and affectsbinding30N4Weak≥ 30 nt16.022.17.513.940.80.0347Binding abolished;deletion likely affectsN5No bindingND15.034.76.914.246.70.0333Exhibits the largest structural perturbationaffecting the binding Impact of mutations on the secondary structure and ssDNA binding activity of Gp13. Deletion likely relieves structural constraints; allows binding to shorter oligos. similar binding behavior to C1 Improved accessibility for short oligos due to N-terminal deletion Significant reduction in antiparallel content suggests reduced stability and affects binding30 Binding abolished; deletion likely affects Exhibits the largest structural perturbation affecting the binding Over-expression and purification of Gp13 Gp13 was over-expressed and purified by standard procedures as described previously15. Briefly, E. coli cells harboring the pGp13 were grown in Luria-Bertani broth supplemented with kanamycin (50 µg/mL) at 37 °C to an OD of 0.3–0.4. The growing cells were then induced for Gp13 expression by the addition of 0.5 mM IPTG. Growth was continued for another 2 h at 37 °C. The induced cells were harvested by centrifugation at 6000 rpm, at 4 °C for 10 min, and the resulting pellet was resuspended in 10 mL of Lysis buffer (20 mM Tris-chloride, pH 7.5, 300 mM NaCl, 5% glycerol, 10 mM imidazole, and 10 µg/mL of PMSF). These resuspended cells were sonicated and the soluble fraction was subjected to affinity chromatography to purify the soluble Gp13 using a Ni-NTA column. The eluted fractions from the column were further purified by dialysis against a Dialysis buffer comprising 20 mM Tris-chloride buffer (pH 7.5), 150 mM NaCl, and 5% glycerol. SDS-15% PAGE was employed to analyze the purity of Gp13. EMSA to assess the binding site size of Gp13 and its terminal deletion mutants The possible functional role of the N-terminal and C-terminal domains of Gp13 in its DNA binding activity is largely unexplored. Earlier studies by Huang et al. on C-terminal domain swapping of SSB proteins in Klebsiella pneumoniae (KpSSB), Salmonella enterica Serovar Typhimurium LT2 (StSSB), and Pseudomonas aeruginosa PAO1 (PaSSB) have shown that SSB’s C-terminal disordered linker region plays a vital role in determining the binding site size49. Since Gp13 has an OB-fold located at the C-terminal end, we wanted to investigate whether deleting the N-terminal and C-terminal amino acids would influence the binding site size. To investigate this, we performed a series of binding assays using the deletion mutants. The binding reactions were performed in a binding buffer (20 mM Tris-chloride, pH 7.5, 150 mM NaCl, 0.2 mM EDTA). Briefly, increasing concentrations (1–3 µM) of each of the purified mutant proteins were incubated with 300 nM of oligo (dT)n (n = 20, 25, 30, 60) at 32 °C for 10 min. The reaction was stopped by adding 3 µl 6X DNA loading dye. The reaction mixtures were visualized and analyzed by the method previously described31. Briefly, a 10% non-denaturing PAGE was employed to resolve the reaction mixtures and SYBR Green II RNA Gel stain (ThermoFisher Scientific) was used to stain the gel. The gel pictures were captured by Gel Capture E-Gel version 1.5.0.0 was employed to capture the gel pictures and analysis of the bands (showing bound and unbound oligonucleotide substrates) was done by ImageJ Version 1.52a [NIH, USA. https://imagej.nih.gov/ij/]. Determination of apparent molecular weights of Gp13 mutants by size-exclusion chromatography The oligomeric state of Gp13 and its deletion mutants in solution was determined by employing Size exclusion chromatography by THEERTHA BIOPHARMA PVT. LTD., Bangalore, India. A Yarra Sect. 2000 column (Internal diameter: 4.6 mm, Length: 300 mm, Particle size: 3 μm, Porosity: 145 Å) was used for all Size exclusion chromatography experiments. Briefly, 10 µl of purified Gp13 and the N-terminal (N1, N2, N4 and N5) and C-terminal deletion mutants (C1 and C2) at 1 mg/ml concentration were loaded onto a Yarra Sect. 2000 column with 0.1 M Sodium Phosphate buffer (pH 7.2). The protein was eluted at a constant flow rate of 0.3 ml/minute. The absorbance of the eluted Gp13 was monitored at 280 nm. Four marker proteins were eluted under similar conditions using the Yarra Sect. 2000 column separately (Fig. 3). The retention factor of each protein was determined. A standard curve was generated with four standard proteins analyzed in the study and used to calculate the molecular mass of the Gp13 and its deletion mutants. Effect of mutation on the secondary and tertiary structure of the proteins The wild-type and the deletion mutants at a final concentration of 10 µM were dialyzed overnight in Dialysis buffer (Tris HCl pH 7.5, NaCl 150 mM and 5% Glycerol) at 4 °C and subjected to CD spectral analysis (wavelength 200–260 nm, bandwidth 2.00 nm, data pitch 0.2 nm) using JASCO CDJ-1500 (JASCO CD/A023661638, JASCO, Easton, MD, USA) in quartz cuvette of 1 mm diameter. The secondary structural elements were analyzed using the BeStSel (β-structure selection) web server32,33. The same protein samples were also used to analyze the alterations in the protein tertiary structure by recording the changes in the intrinsic tryptophan fluorescence. Pull-down assay To investigate the interaction of Gp13 and C1 with RecA, a pull-down assay was performed with tag-less RecA. His-tag was removed from RecA using TEV protease (P8112S, New England Biolabs). Gp13 (10 µM) or C1 (10 µM) was incubated with ssDNA {(dT)₅₀} (5 µM) for 5 min in binding buffer (20 mM phosphate buffer pH 8, 10 mM MgCl₂, 50 mM NaCl) at room temperature followed by addition of RecA (50 µM) and ATP (2 mM) and incubation for 5 min at 25 °C. The reaction mixtures were applied separately to the HisPur™ Ni-NTA resin beads (Thermo Scientific) pre-equilibrated in Buffer B1 (20 mM Phosphate Buffer pH 8, 50 mM NaCl, 10 mM imidazole). The resin was washed gently with Buffer B2 (20 mM Phosphate Buffer pH 8, 100 mM NaCl, 20 mM imidazole) and the bound complex was eluted with Elution Buffer (20 mM Phosphate Buffer pH 8, 100 mM NaCl, 250 mM imidazole). The eluted proteins were analyzed by SDS-15% PAGE8,46,50. Supplementary Information Below is the link to the electronic supplementary material. Supplementary Material 1 Supplementary Material 1 Supplementary Material 2 Supplementary Material 2